GLP1R and metabolic syndrome: For example, GLP-1 drugs such as semaglutide and dulaglutide treat diabetes and obesity, exhibit blood pressure and LDL-lowering effects, and have potential benefits for dementia, sleep apnea (a common MetS comorbidity), and osteoporosis [42,43,44].